Supplemental Financial Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Accrued compensation	$ 5,242	$ 3,423
Accrued clinical trial	1,907	1,851
Lease liabilities, current portion	1,877	1,646
Accrued research and development	1,714	3,467
Accrued professional and consulting fees	725	330
Warrant liability	438	454
Accrued property, plant and equipment	207
Accrued severance		390
Other	752	723
Total accrued expenses and other current liabilities	$ 12,862	$ 12,284